Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Vincristine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 194 Precursor Cell Lymphoblastic Leukemia-Lymphoma 167 Lymphoma, Large B-Cell, Diffuse 160 Leukemia 93 Burkitt Lymphoma 82 Lymphoma, Non-Hodgkin 80 Lymphoma, Follicular 73 Lymphoma, Mantle-Cell 50 Hodgkin Disease 43 Neuroblastoma 40 Central Nervous System Neoplasms 38 Sarcoma 34 Lymphoma, B-Cell 27 Lymphoma, Large-Cell, Immunoblastic 26 Lymphoma, Large-Cell, Anaplastic 26 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25 Lymphoma, T-Cell, Peripheral 24 Rhabdomyosarcoma 21 Recurrence 21 Lymphoma, B-Cell, Marginal Zone 21 Neoplasms 20 Multiple Myeloma 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Medulloblastoma 18 Brain Neoplasms 18 Sarcoma, Ewing 17 Leukemia, Biphenotypic, Acute 16 HIV Infections 16 Dendritic Cell Sarcoma, Interdigitating 16 Retinoblastoma 14

Interventions

Trastuzumab 556 Paclitaxel 513 Cyclophosphamide 491 Docetaxel 431 Capecitabine 372 Letrozole 336 Fulvestrant 292 Doxorubicin 262 Tamoxifen 245 Carboplatin 243 Anastrozole 211 Radiotherapy 201 exemestane 199 Epirubicin 180 Bevacizumab 178 palbociclib 170 Lapatinib 156 Vinorelbine 155 pertuzumab 152 Gemcitabine 151 pembrolizumab 146 Surveys and Questionnaires 124 Exercise 119 Magnetic Resonance Spectroscopy 117 eribulin 108 Albumin-Bound Paclitaxel 108 Fluorouracil 105 Blood Specimen Collection 103 130-nm albumin-bound paclitaxel 99 Everolimus 94

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02299999 2025-01-15

SAFIR02_Breast

UNICANCER

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡